IRVINE, Calif., April 14, 2015 (GLOBE NEWSWIRE) -- Praxsyn Corporation's (OTCQB:PXYN) wholly owned subsidiary, Mesa Pharmacy Inc. (Mesa), entered into a Business Associate Agreement with Products for Doctors for marketing and other services on January 23, 2015. The non-exclusive agreement between Products for Doctors and Mesa facilitates the marketing of Mesa's products to medical providers throughout California.
"After our first meeting with the executive team at Mesa Pharmacy, we knew that we wanted to join their team," said James Bradford, Executive Partner, Products for Doctors. "Mesa is a breath of fresh air for the pharmaceutical industry and we are thrilled to be working with such an accountable and passionate team."
"We are excited to be working with a family-oriented company like our own who believe integrity and transparency are key factors in creating a prosperous business," said Kelly Reynolds, CEO, Mesa Pharmacy.
Products for Doctors was established in 2013 when partners, James Bradford and Richard Valenta, saw the need for a non-narcotic approach to medicine. The partners began a physicians practice enhancement firm in order to help physicians provide better patient care, while also enhancing revenue for its clients. Since 2013, Products for Doctors has experienced significant growth, lending to its highly regarded reputation.
About Praxsyn Corporation
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements regarding the past performance and anticipated results of the business associate agreement with Products for Doctors, Inc. and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.